TransEnterix Announces Submission of 510(k) to FDA for First Machine Vision System in Robotic Surgery
https://www.businesswire.com/news/home/20200114005251/en/
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan 14, 2020--
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company filed a 510(k) submission with an Intelligent Surgical Unit (ISU TM ) 1 that is designed to enable machine vision capabilities on the Senhance Ⓡ Surgical System.
